Amalgamated Bank decreased its stake in shares of CEVA, Inc. (NASDAQ:CEVA – Free Report) by 9.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,893 shares of the semiconductor company’s stock after selling 721 shares during the quarter. Amalgamated Bank’s holdings in CEVA were worth $133,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of CEVA. Vanguard Group Inc. increased its stake in shares of CEVA by 2.2% during the first quarter. Vanguard Group Inc. now owns 2,969,107 shares of the semiconductor company’s stock worth $67,428,000 after buying an additional 62,734 shares during the period. Dimensional Fund Advisors LP lifted its position in shares of CEVA by 5.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 835,131 shares of the semiconductor company’s stock worth $16,110,000 after purchasing an additional 44,502 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of CEVA by 8.3% during the second quarter. Acadian Asset Management LLC now owns 566,880 shares of the semiconductor company’s stock worth $10,931,000 after purchasing an additional 43,266 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in CEVA by 1,693.8% in the first quarter. CANADA LIFE ASSURANCE Co now owns 321,602 shares of the semiconductor company’s stock valued at $7,284,000 after buying an additional 303,673 shares during the last quarter. Finally, Silverberg Bernstein Capital Management LLC raised its stake in CEVA by 3.9% in the second quarter. Silverberg Bernstein Capital Management LLC now owns 71,824 shares of the semiconductor company’s stock valued at $1,385,000 after buying an additional 2,700 shares in the last quarter. Institutional investors and hedge funds own 85.37% of the company’s stock.
CEVA Stock Down 1.1 %
Shares of NASDAQ CEVA opened at $23.88 on Wednesday. The business has a 50-day moving average price of $22.34 and a 200 day moving average price of $21.11. The stock has a market cap of $565.72 million, a PE ratio of -45.06 and a beta of 1.19. CEVA, Inc. has a 52-week low of $16.02 and a 52-week high of $25.54.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on CEVA shares. Roth Mkm raised CEVA from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $20.00 to $25.00 in a research report on Thursday, August 8th. Oppenheimer increased their price target on shares of CEVA from $29.00 to $33.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Finally, StockNews.com downgraded shares of CEVA from a “buy” rating to a “hold” rating in a research report on Wednesday, August 21st. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CEVA currently has a consensus rating of “Moderate Buy” and an average price target of $28.50.
Read Our Latest Analysis on CEVA
About CEVA
CEVA, Inc provides silicon and software IP solutions to semiconductor and original equipment manufacturer (OEM) companies worldwide. Its 5G mobile and infrastructure products include Ceva-XC vector digital signal processors (DSPs) for 5G handsets, 5G RAN, and general-purpose baseband processing; PentaG-RAN, an open ran platform for base station and radio; and PentaG2 – 5G NR modem platform for UE, as well as for non-handset 5G vertical markets, such as fixed wireless access, industry 4.0, robotics, and AR/VR devices.
Featured Articles
- Five stocks we like better than CEVA
- What Are Dividend Contenders? Investing in Dividend Contenders
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Election Stocks: How Elections Affect the Stock Market
- 2 Energy Stocks Fueling the AI Datacenter Boom
- How Can Investors Benefit From After-Hours Trading
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for CEVA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEVA and related companies with MarketBeat.com's FREE daily email newsletter.